PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
-16.50%
Revenue decline while VET shows 3.74% growth. Joel Greenblatt would examine competitive position erosion.
5.68%
Cost growth 50-75% of VET's 9.41%. Bruce Berkowitz would examine sustainable cost advantages.
-25.93%
Both companies show declining gross profit. Martin Whitman would check industry conditions.
-11.30%
Both companies show margin pressure. Martin Whitman would check industry conditions.
No Data
No Data available this quarter, please select a different quarter.
-14.81%
Both companies reducing G&A. Martin Whitman would check industry cost trends.
No Data
No Data available this quarter, please select a different quarter.
-92.39%
Other expenses reduction while VET shows 250.00% growth. Joel Greenblatt would examine efficiency.
-14.53%
Operating expenses reduction while VET shows 7.50% growth. Joel Greenblatt would examine advantage.
-4.75%
Total costs reduction while VET shows 8.59% growth. Joel Greenblatt would examine advantage.
-10.23%
Interest expense reduction while VET shows 5.53% growth. Joel Greenblatt would examine advantage.
3.21%
D&A growth less than half of VET's 9.41%. David Dodd would verify if efficiency is sustainable.
-23.73%
EBITDA decline while VET shows 0.53% growth. Joel Greenblatt would examine position.
-17.13%
Both companies show margin pressure. Martin Whitman would check industry conditions.
-35.41%
Both companies show declining income. Martin Whitman would check industry conditions.
-22.65%
Both companies show margin pressure. Martin Whitman would check industry conditions.
110.91%
Other expenses growth while VET reduces costs. John Neff would investigate differences.
-24.65%
Both companies show declining income. Martin Whitman would check industry conditions.
-9.77%
Both companies show margin pressure. Martin Whitman would check industry conditions.
-233.33%
Both companies reducing tax expense. Martin Whitman would check patterns.
-23.20%
Net income decline while VET shows 8.36% growth. Joel Greenblatt would examine position.
-8.03%
Net margin decline while VET shows 4.45% growth. Joel Greenblatt would examine position.
-22.73%
EPS decline while VET shows 5.26% growth. Joel Greenblatt would examine position.
-22.73%
Diluted EPS decline while VET shows 5.41% growth. Joel Greenblatt would examine position.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.